Cardiovascular diseases (CVD) have been on the rise across the globe and have seen exponential growth due to lifestyle disorders. To address this growing concern, the World Heart Federation observes September 29 as ‘World Heart Day’, every year. This year the primary goal for World Heart Day 2021 is ‘Globally harnessing the power of digital health to improve awareness, prevention and management of CVD’.
Cardiovascular diseases such as ischemic heart disease and stroke account for 17.7 million deaths in India and a significant patient pool involves younger population, according to the World Health Organisation (WHO). COVID-19 pandemic has added fuel to fire as it has been found that the virus can act as an independent driver for heart attack. Having said that, the world is witnessing a plethora of technological innovations in this space, saving numerous lives. India is not far behind and the country has witnessed significant improvements in heart care in the past decade.
According to a recent report by Mordor Intelligence, the market for cardiovascular devices in India consists of several global players along with the local players. However, the number of local players in the country is less and the market is dominated by global companies such as Abbott, Boston Scientific, Medtronic, etc. Since India is a growing economy, more global companies are expected to penetrate the market in the coming years.
New age technological advancements
This story is from the September 2021 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the September 2021 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities
Agilent Technologies Inc. has announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions.
Univercells Technologies launches miniaturised scale-X Nexo Bioreactor
Univercells Technologies has announced the launch of its latest innovation, the scale-X nexo bioreactor.
Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics
Thermo Fisher Scientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to establish a Bioprocess Design Centre (BDC) in Genome Valley, Hyderabad.
VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors
Chennai-based VFL Sciences has announced the launch of GreatFlo Parallel, a range of seamlessly parallel Bioreactors and Fermentors at the IKMC 2024 event organised by IKP Knowledge Park at Hyderabad recently, by Dr Jitendra Kumar, Managing Director, BIRAC.
Avantor opens new innovation centre for solving life science's biggest challenges
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has announced the opening of its new flagship Bridgewater Innovation Centre.
Waters unveils new software to deliver lab-centric business intelligence
Waters Corporation has announced the launch of waters connect Data Intelligence software, a new cloud-based application that helps customers in regulated industries improve how they access, organise, analyse, and drive productivity from laboratory information.
INST develops unique drug delivery method to improve treatment of brain TB
Researchers at the Institute of Nano Science and Technology (INST), Mohali, have created a unique way to deliver Tuberculosis (TB) medicines directly to the brain bypassing the challenging blood-brain barrier (BBB) that limits the effectiveness of many brain TB medicines.
New way to create hydrogels from viral protein fragments for improving drug delivery
Researchers from Bose Institute, an autonomous institute of the Department of Science and Technology (DST), in Kolkata, have discovered a new way to create hydrogels using tiny protein fragments of just five amino acids from the SARS-CoV-1 virus, that could help improve targeted drug delivery & reduce side effects.
Lupin appoints Claus Jepsen as President, Global Specialty
Global pharma major Lupin has announced the appointment of Claus Jepsen as President, Global Specialty.
Shyamakant Giri to join as CEO of Gland Pharma
Gland Pharma’s Board has approved the appointment of Shyamakant Giri, as the new Chief Executive Officer (CEO) of the company.